Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Update on the role of autologous hematopoietic stem cell transplantation in follicular lymphoma.

Cabrero M, Redondo A, Martin A, Caballero D.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012074. doi: 10.4084/MJHID.2012.074. Epub 2012 Nov 7.

2.

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.

Schaaf M, Reiser M, Borchmann P, Engert A, Skoetz N.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD007678. doi: 10.1002/14651858.CD007678.pub2. Review.

PMID:
22258971
3.

A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma.

Sabloff M, Atkins HL, Bence-Bruckler I, Bredeson C, Fergusson D, Genest P, Hopkins H, Hutton B, Mcdiarmid S, Huebsch LB.

Biol Blood Marrow Transplant. 2007 Aug;13(8):956-64.

4.

The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era.

Maura F, Farina L, Corradini P.

Mediterr J Hematol Infect Dis. 2016 Sep 1;8(1):e2016045. doi: 10.4084/MJHID.2016.045. eCollection 2016. Review.

5.

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure.

Kothari J, Peggs KS, Bird A, Thomson KJ, Morris E, Virchis AE, Lambert J, Goldstone AH, Linch DC, Ardeshna KM.

Br J Haematol. 2014 May;165(3):334-40. doi: 10.1111/bjh.12741. Epub 2014 Jan 18.

PMID:
24438080
6.

Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.

Tomblyn MR, Ewell M, Bredeson C, Kahl BS, Goodman SA, Horowitz MM, Vose JM, Negrin RS, Laport GG.

Biol Blood Marrow Transplant. 2011 Jul;17(7):1051-7. doi: 10.1016/j.bbmt.2010.11.004. Epub 2010 Nov 10.

7.

Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.

Peters AC, Duan Q, Russell JA, Duggan P, Owen C, Stewart DA.

Leuk Lymphoma. 2011 Nov;52(11):2124-9. doi: 10.3109/10428194.2011.594925. Epub 2011 Jul 8.

PMID:
21740097
8.

Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma.

Bhatt VR, Armitage JO.

Expert Opin Biol Ther. 2016;16(1):57-66. doi: 10.1517/14712598.2016.1096341. Epub 2015 Oct 29. Review.

PMID:
26515478
9.

PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.

Alcantara M, Dupuis J, Mareschal S, Julian A, Cottereau AS, Becker S, Dubois S, Oberic L, Huynh A, Meignan M, Laurent G, Tilly H, Haioun C, Ysebaert L.

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):215-21. doi: 10.1007/s00259-014-2896-2. Epub 2014 Sep 20.

PMID:
25239490
10.

Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.

Derenzini E, Musuraca G, Fanti S, Stefoni V, Tani M, Alinari L, Venturini F, Gandolfi L, Baccarani M, Zinzani PL.

Cancer. 2008 Nov 1;113(9):2496-503. doi: 10.1002/cncr.23861.

11.

Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis.

Wang B, Ren C, Zhang W, Ma X, Xia B, Sheng Z.

Hematol Oncol. 2013 Mar;31(1):29-33. doi: 10.1002/hon.2015. Epub 2012 Apr 4.

PMID:
22488650
12.

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.

Gyan E, Foussard C, Bertrand P, Michenet P, Le Gouill S, Berthou C, Maisonneuve H, Delwail V, Gressin R, Quittet P, Vilque JP, Desablens B, Jaubert J, Ramée JF, Arakelyan N, Thyss A, Moluçon-Chabrot C, Delépine R, Milpied N, Colombat P, Deconinck E; Groupe Ouest-Est des Leucémies et des Autres Maladies du Sang (GOELAMS).

Blood. 2009 Jan 29;113(5):995-1001. doi: 10.1182/blood-2008-05-160200. Epub 2008 Oct 27.

13.

Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience.

López R, Martino R, Sureda A, Nomdedéu J, Briones J, Martin-Henao G, García J, Brunet S, Sierra J.

Haematologica. 1999 Apr;84(4):350-5.

15.

Autologous transplant of follicular lymphoma in the era of rituximab.

Witzens-Harig M, Dreger P.

Leuk Lymphoma. 2010 Jun;51(6):967-74. doi: 10.3109/10428191003793341. Review.

PMID:
20443675
16.

Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?

Seyfarth B, Kuse R, Sonnen R, Glass B, Schmitz N, Dreger P.

Ann Hematol. 2001 Jul;80(7):398-405.

PMID:
11529465
17.

Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.

Pettengell R, Schmitz N, Gisselbrecht C, Smith G, Patton WN, Metzner B, Caballero D, Tilly H, Walewski JA, Bence-Bruckler I, To B, Geisler CH, Schots R, Kimby E, Taverna CJ, Kozák T, Dreger P, Uddin R, Ruiz de Elvira C, Goldstone AH.

J Clin Oncol. 2013 May 1;31(13):1624-30. doi: 10.1200/JCO.2012.47.1862. Epub 2013 Apr 1.

PMID:
23547078
18.

Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma.

Kang TY, Rybicki LA, Bolwell BJ, Thakkar SG, Brown S, Dean R, Sekeres MA, Advani A, Sobecks R, Kalaycio M, Pohlman B, Sweetenham JW.

Bone Marrow Transplant. 2007 Nov;40(10):973-8. Epub 2007 Sep 17.

PMID:
17873917
19.

High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma.

Oyan B, Koc Y, Ozdemir E, Kars A, Turker A, Tekuzman G, Kansu E.

Leuk Lymphoma. 2006 Aug;47(8):1545-52.

PMID:
16966265
20.

Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.

Ganguly S, Divine CL, Deauna-Limayo D, Bodensteiner DC, Cook JD, Lewis JN, Skikne BS.

Ann Hematol. 2005 Aug;84(8):526-31. Epub 2005 May 25.

PMID:
15915350

Supplemental Content

Support Center